14h
Hosted on MSNNew Lipid Nanoparticles Deliver mRNA for Lung Tissue RegenerationNew research from the Perelman School of Medicine at the University of Pennsylvania suggests that a combination of messenger ...
An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...
A young Peninsula drugmaker won regulatory approval Friday for a rare-disease drug picked up in a deal two years ago.
Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global ...
Scientists in China have discovered a cholesterol-related compound that may contribute to the development of Parkinson’s disease. This compound, called 24-OHC, appears to help spread harmful protein ...
The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...
Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug indicated for the rare lipid storage disease and autosomal recessive genetic ...
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
Nematodes have oily surfaces that impact survival and interactions, offering insights into evolution and parasite control. A ...
The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...
Oxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results